StockData
Sera Prognostics, Inc. logo

Sera Prognostics, Inc. (SERA) income statement

SERANasdaqServices-Medical LaboratoriesFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 5/30
$1.91−0.09 (-4.50%)

Close on Nov 18, 2026Market cap $75.35MP/E –Yield –

Sera Prognostics, Inc. income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin
-150.0%
Operating margin
-53282.9%
Net margin
-47475.7%
Return on equity, FY2025
-51.8%

Financial strength

Current ratio
1.98
Debt to equity
–
Debt to assets
–
Cash to current liabilities
18.1%

Valuation

P/E ratio
–
Price to sales
1076.41
Price to book
1.27
Dividend yield
–

See a number that looks wrong?